Log in to save to my catalogue

Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metas...

Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metas...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8586672

Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis

About this item

Full title

Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2021-11, Vol.112 (11), p.4470-4477

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Fusobacterium nucleatum has been detected in 8%‐13% of human colorectal cancer, and shown to inhibit immune responses against primary colorectal tumors in animal models. Thus, we hypothesized that the presence of F. nucleatum might be associated with reduced T cell density in colorectal cancer liver metastases (CRLM). We quantified F. nucleatum DNA...

Alternative Titles

Full title

Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8586672

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8586672

Other Identifiers

ISSN

1347-9032,1349-7006

E-ISSN

1349-7006

DOI

10.1111/cas.15126

How to access this item